IDNA vs. SLV

Last updated Jun 3, 2026

IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and SLV (iShares Silver Trust) are both exchange-traded funds - IDNA is a Health & Biotech Equities fund tracking the NYSE FactSet Global Genomics and Immuno Biopharma Index, while SLV is a Silver fund tracking the LBMA Silver Price. Both are passively managed. Over the past 5 years, IDNA returned -8.26%/yr vs 21.71%/yr for SLV. At a 0.21 correlation, their price movements are largely independent. IDNA charges 0.47%/yr vs 0.50%/yr for SLV.

Performance

IDNA vs. SLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Silver Trust (SLV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IDNA achieves a 9.51% return, which is significantly higher than SLV's 5.54% return.

IDNA

• 1D: -2.18%
• 1M: -2.18%
• YTD: 9.51%
• 6M: 10.53%
• 1Y: 41.74%
• 3Y*: 6.48%
• 5Y*: -8.26%
• 10Y*: —

SLV

• 1D: 0.47%
• 1M: -0.44%
• YTD: 5.54%
• 6M: 27.97%
• 1Y: 115.23%
• 3Y*: 46.35%
• 5Y*: 21.71%
• 10Y*: 15.85%

*Multi-year figures are annualized to reflect compound growth (CAGR)

IDNA vs. SLV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund	9.51%	17.26%	-0.72%	-7.63%	-42.28%	-3.98%	54.30%	20.83%
SLV iShares Silver Trust	5.54%	144.66%	20.89%	-1.09%	2.37%	-12.45%	47.30%	19.48%

Correlation

The correlation between IDNA and SLV is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.26
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jun 14, 2019	0.21

IDNA vs. SLV - Sectors Allocation Comparison

Sectors	IDNA	SLV
Healthcare	97.8%	-
Industrials	0.4%	-
Basic Materials	-	100.0%
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

IDNA vs. SLV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDNA

IDNA Risk / Return Rank: 57
IDNA Sharpe Ratio Rank: 49
IDNA Sortino Ratio Rank: 50
IDNA Omega Ratio Rank: 43
IDNA Calmar Ratio Rank: 79
IDNA Martin Ratio Rank: 64

SLV

SLV Risk / Return Rank: 52
SLV Sharpe Ratio Rank: 57
SLV Sortino Ratio Rank: 42
SLV Omega Ratio Rank: 59
SLV Calmar Ratio Rank: 59
SLV Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDNA vs. SLV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Silver Trust (SLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IDNA	SLV	Difference
Sharpe ratio Return per unit of total volatility	1.71	1.97	-0.26
Sortino ratio Return per unit of downside risk	2.48	2.12	+0.36
Omega ratio Gain probability vs. loss probability	1.28	1.36	-0.08
Calmar ratio Return relative to maximum drawdown	4.09	2.98	+1.11
Martin ratio Return relative to average drawdown	11.79	6.48	+5.30
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IDNA vs. SLV - Sharpe Ratio Comparison

The current IDNA Sharpe Ratio is 1.71, which is comparable to the SLV Sharpe Ratio of 1.97. The chart below compares the historical Sharpe Ratios of IDNA and SLV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	IDNA	SLV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.71	1.97	-0.26
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.29	0.60	-0.90
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.50	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.10	0.25	-0.15

Drawdowns

IDNA vs. SLV - Drawdown Comparison

The maximum IDNA drawdown since its inception was -68.26%, smaller than the maximum SLV drawdown of -76.28%. Use the drawdown chart below to compare losses from any high point for IDNA and SLV.

Drawdown Indicators

	IDNA	SLV	Difference
Max Drawdown Largest peak-to-trough decline	-68.26%	-76.28%	+8.02%
Max Drawdown (1Y) Largest decline over 1 year	-10.66%	-42.45%	+31.79%
Max Drawdown (3Y) Largest decline over 3 years	-29.73%	-42.45%	+12.72%
Max Drawdown (5Y) Largest decline over 5 years	-68.26%	-42.45%	-25.81%
Max Drawdown (10Y) Largest decline over 10 years	—	-42.81%	—
Current Drawdown Current decline from peak	-46.01%	-35.62%	-10.39%
Average Drawdown Average peak-to-trough decline	-36.24%	-44.67%	+8.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.70%	19.53%	-15.83%

Volatility

IDNA vs. SLV - Volatility Comparison

The current volatility for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) is 7.24%, while iShares Silver Trust (SLV) has a volatility of 16.47%. This indicates that IDNA experiences smaller price fluctuations and is considered to be less risky than SLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IDNA	SLV	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.24%	16.47%	-9.23%
Volatility (6M) Calculated over the trailing 6-month period	18.21%	58.29%	-40.08%
Volatility (1Y) Calculated over the trailing 1-year period	24.51%	59.03%	-34.52%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.42%	36.15%	-7.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	29.53%	31.83%	-2.30%

IDNA vs. SLV - Expense Ratio Comparison

IDNA has a 0.47% expense ratio, which is lower than SLV's 0.50% expense ratio.

Dividends

IDNA vs. SLV - Dividend Comparison

IDNA's dividend yield for the trailing twelve months is around 1.08%, while SLV has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund	1.08%	1.18%	0.98%	1.04%	0.54%	0.70%	0.26%	0.80%
SLV iShares Silver Trust	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both IDNA and SLV in my portfolio?

IDNA and SLV have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IDNA or SLV?

SLV has higher volatility (16.47%) compared to IDNA (7.24%). In terms of maximum drawdown, IDNA dropped -68.26% vs SLV's -76.28%.

Which ETF is better, IDNA or SLV?

On 5-year performance, SLV leads with 21.71% vs -8.26% for IDNA. On fees, IDNA is cheaper at 0.47% per year. On volatility, IDNA has been the lower-risk option at 7.24%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, IDNA or SLV?

Over the 5-year period, SLV has performed better with a 21.71% return vs -8.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, IDNA or SLV?

IDNA is cheaper with a 0.47% expense ratio, compared with 0.50% for SLV.

Which ETF pays a higher dividend yield, IDNA or SLV?

IDNA has the higher dividend yield at 1.08%, compared with 0.00% for SLV.

What is the main difference between IDNA and SLV?

IDNA is categorized as Health & Biotech Equities, while SLV is Silver. IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while SLV tracks LBMA Silver Price. Their fees differ too: 0.47% for IDNA and 0.50% for SLV.

Which has better risk-adjusted returns?

SLV currently has the higher Sharpe Ratio (1.97 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.